BRANDICOURT OLIVIER bought PCVX
January 15, 2026 · Form 4 insider transaction
BRANDICOURT OLIVIER bought 1,357 shares of Vaxcyte, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
1,357
Price
$0.00
Total value
N/A
InsiderBRANDICOURT OLIVIER
Role—
CompanyVaxcyte, Inc. (PCVX)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJanuary 15, 2026
Filing dateJanuary 16, 2026
Shares owned after2,505
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents the number of shares of Common Stock underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs will fully vest on the earlier of June 12, 2026 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date.